Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A Scrna‐seq Analysis

Chen Xue,Xinyu Gu,Qiuxian Zheng,Qingmiao Shi,Xin Yuan,Qingfei Chu,Junjun Jia,Yuanshuai Su,Zhengyi Bao,Juan Lu,Lanjuan Li
DOI: https://doi.org/10.1002/advs.202207074
IF: 15.1
2023-01-01
Advanced Science
Abstract:Kynurenine derivative 3-hydroxyanthranilic acid (3-HAA) is known to regulate the immune system and exhibit anti-inflammatory activity by inhibiting T-cell cytokine secretion and influencing macrophage activity. However, the definite role of 3-HAA in the immunomodulation of hepatocellular carcinoma (HCC) is largely unexplored. An orthotopic HCC model and treated with 3-HAA by intraperitoneal injection is developed. Furthermore, cytometry by time-of-flight (CyTOF) and single-cell RNA sequencing (scRNA-seq) analyses are carried out to define the immune landscape of HCC. It is found that 3-HAA treatment can significantly suppress tumor growth in the HCC model and alter the level of various cytokines in plasma. CyTOF data shows that 3-HAA significantly increases the percentage of F4/80(hi)CX3CR1(lo)Ki67(lo)MHCII(hi) macrophages and decreases the percentage of F4/80(lo)CD64(+)PD-L1(lo) macrophages. scRNA-seq analyses demonstrate that 3-HAA treatment is proved to regulate the function of M1 macrophages, M2 macrophages, and proliferating macrophages. Notably, 3-HAA inhibits the proinflammatory factors TNF and IL-6 in multiple cell subsets, including resident macrophages, proliferating macrophages, and pDCs. This study reveals the landscape of immune cell subsets in HCC in response to 3-HAA, indicating that 3-HAA may be a promising therapeutic target for HCC.
What problem does this paper attempt to address?